Literature DB >> 29299455

Ezh2-dependent therapies in bladder cancer: synthetic lethality.

Cristina Segovia1,2,3, Jesús M Paramio1,2,3.   

Abstract

Entities:  

Year:  2017        PMID： 29299455      PMCID： PMC5750286          DOI： 10.21037/atm.2017.10.08

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  22 in total

Review 1.  Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise.

Authors:  Jaegil Kim; Rehan Akbani; Chad J Creighton; Seth P Lerner; John N Weinstein; Gad Getz; David J Kwiatkowski
Journal:  Clin Cancer Res       Date:  2015-10-15       Impact factor: 12.531

Review 2.  Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.

Authors:  Margaret A Knowles; Carolyn D Hurst
Journal:  Nat Rev Cancer       Date:  2015-01       Impact factor: 60.716

3.  Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner.

Authors:  Makiko Mochizuki-Kashio; Kazumasa Aoyama; Goro Sashida; Motohiko Oshima; Takahisa Tomioka; Tomoya Muto; Changshan Wang; Atsushi Iwama
Journal:  Blood       Date:  2015-07-28       Impact factor: 22.113

Review 4.  ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.

Authors:  Maximilian Burger; Willem Oosterlinck; Badrinath Konety; Sam Chang; Sigurdur Gudjonsson; Raj Pruthi; Mark Soloway; Eduardo Solsona; Paul Sved; Marko Babjuk; Maurizio A Brausi; Christopher Cheng; Eva Comperat; Colin Dinney; Wolfgang Otto; Jay Shah; Joachim Thürof; J Alfred Witjes
Journal:  Eur Urol       Date:  2012-09-05       Impact factor: 20.096

Review 5.  Targeting EZH2 in cancer.

Authors:  Kimberly H Kim; Charles W M Roberts
Journal:  Nat Med       Date:  2016-02       Impact factor: 53.440

6.  Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia.

Authors:  Panagiotis Ntziachristos; Aristotelis Tsirigos; Pieter Van Vlierberghe; Jelena Nedjic; Thomas Trimarchi; Maria Sol Flaherty; Dolors Ferres-Marco; Vanina da Ros; Zuojian Tang; Jasmin Siegle; Patrik Asp; Michael Hadler; Isaura Rigo; Kim De Keersmaecker; Jay Patel; Tien Huynh; Filippo Utro; Sandrine Poglio; Jeremy B Samon; Elisabeth Paietta; Janis Racevskis; Jacob M Rowe; Raul Rabadan; Ross L Levine; Stuart Brown; Francoise Pflumio; Maria Dominguez; Adolfo Ferrando; Iannis Aifantis
Journal:  Nat Med       Date:  2012-02-06       Impact factor: 53.440

7.  Epigenetic alterations in bladder cancer and their potential clinical implications.

Authors:  Han Han; Erika M Wolff; Gangning Liang
Journal:  Adv Urol       Date:  2012-06-21

Review 8.  EZH2 in Bladder Cancer, a Promising Therapeutic Target.

Authors:  Mónica Martínez-Fernández; Carolina Rubio; Cristina Segovia; Fernando F López-Calderón; Marta Dueñas; Jesús M Paramio
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

9.  Comprehensive molecular characterization of urothelial bladder carcinoma.

Authors: 
Journal:  Nature       Date:  2014-01-29       Impact factor: 49.962

Review 10.  Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.

Authors:  Ludovica Morera; Michael Lübbert; Manfred Jung
Journal:  Clin Epigenetics       Date:  2016-05-24       Impact factor: 6.551
View more
  3 in total

1.  Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.

Authors:  Zegui Tu; Xiancheng Chen; Tian Tian; Guo Chen; Meijuan Huang
Journal:  Aging (Albany NY)       Date:  2021-02-26       Impact factor: 5.682

2.  Nodal regulates bladder cancer cell migration and invasion via the ALK/Smad signaling pathway.

Authors:  Youkong Li; Wen Zhong; Min Zhu; Shengguo Hu; Xiaokang Su
Journal:  Onco Targets Ther       Date:  2018-10-05       Impact factor: 4.147

Review 3.  Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet.

Authors:  Victor G Martinez; Ester Munera-Maravilla; Alejandra Bernardini; Carolina Rubio; Cristian Suarez-Cabrera; Cristina Segovia; Iris Lodewijk; Marta Dueñas; Mónica Martínez-Fernández; Jesus Maria Paramio
Journal:  Front Genet       Date:  2019-11-18       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.